University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
GI Quality Improvement Consortium, Bethesda, Maryland, USA.
Am J Gastroenterol. 2019 Aug;114(8):1256-1264. doi: 10.14309/ajg.0000000000000184.
Guidelines recommend that patients with non-dysplastic Barrett's esophagus (NDBE) undergo surveillance endoscopy every 3-5 years. Using a national registry, we assessed compliance to recommended surveillance intervals in patients with NDBE and identified factors associated with compliance.
We analyzed data from the GI Quality Improvement Consortium registry. Data abstracted include procedure indication, demographics, endoscopy/pathology results, and recommendations for future endoscopy. Patients with an indication of Barrett's esophagus (BE) screening or surveillance, or an endoscopic finding of BE, with non-dysplastic intestinal metaplasia on pathological examination, were included. Compliance was defined as a recommendation to undergo subsequent endoscopy between 3 and 5 years. Multivariate logistic regression was conducted to assess variables associated with compliance.
Of 786,712 endoscopies assessed, 58,709 (7.5%) endoscopies in 53,541 patients met inclusion criteria (mean age 61.3 years, 60.4% men, 90.2% white, mean BE length was 2.3 cm). Most cases were performed by Gastroenterologists (92.3%) with propofol (78.7%). A total of 29,978 procedures (55.8%) resulted in pathology-confirmed BE. Among procedures with NDBE (n = 25,945), 29.9% were noncompliant with the 3-year threshold; most (26.9%) recommended surveillance at 1- to 2-year intervals. Patient factors such as extremes of age, black race, geographic region, type of sedation, and increasing BE length were associated with noncompliance.
Approximately 30% of patients with NDBE are recommended to undergo surveillance endoscopy too soon. Patient factors associated with inappropriate utilization include extremes of age, black race, and increasing BE length. Compliance with appropriate endoscopic follow-up as a quality measure in BE is poor.
指南建议非异型增生性 Barrett 食管(NDBE)患者每 3-5 年进行一次内镜监测。本研究使用国家注册中心,评估了 NDBE 患者遵循推荐监测间隔的情况,并确定了与依从性相关的因素。
我们分析了 GI 质量改进联盟注册中心的数据。提取的数据包括程序指征、人口统计学、内镜/病理结果以及对未来内镜的建议。纳入有 Barrett 食管(BE)筛查或监测指征、内镜发现 BE 伴病理检查非异型性肠上皮化生、内镜下表现为 BE 的患者。依从性定义为推荐在 3 至 5 年内进行后续内镜检查。采用多变量逻辑回归评估与依从性相关的变量。
在评估的 786712 例内镜中,58709 例(7.5%)内镜 53541 例患者符合纳入标准(平均年龄 61.3 岁,男性占 60.4%,90.2%为白人,平均 BE 长度为 2.3cm)。大多数病例由胃肠病学家(92.3%)使用异丙酚(78.7%)进行。共有 29978 例(55.8%)操作的病理结果证实为 BE。在有 NDBE 的操作中(n=25945),29.9%不符合 3 年的时间阈值;大多数(26.9%)建议在 1-2 年内进行监测。患者因素如年龄极端、黑种人、地理位置、镇静类型和 BE 长度增加与不依从有关。
大约 30%的 NDBE 患者被推荐进行过早的内镜监测。与不适当利用相关的患者因素包括年龄极端、黑种人和 BE 长度增加。BE 作为一种质量指标,其适当内镜随访的依从性较差。